Home
Surmodics

Surmodics Market Share Analysis for May 2026

Surmodics is the recognized industry leader in surface technology for intravascular medical devices. Our high-performance hydrophilic, drug-delivery and hemocompatible coatings are used on market-leading devices in all major intravascular categories.

Heavy Industry and Engineering > Chemical Industry

Domainsurmodics.com

Year Founded1979

Employees201 - 500

Annual Revenue$100M - $200M

Surmodics

Surmodics (including company regionals)

surmodics.com

See more website traffic and engagement information

Surmodics Revenue up to May 2026 is 100M - 200M

revenue generated by Surmodics top domains

Surmodics top domains revenue over 3 years

Revenue for Surmodics top domains

surmodics.com100M - 200M

See more with Sales Intelligence

Total visits to Surmodics's top domains

Understand Surmodics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

surmodics.com9.9K

See more with Sales Intelligence

Avg. visit duration in Surmodics's top domains

Analyze Surmodics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

surmodics.com00:01:06

See more with Sales Intelligence

Avg. pageviews on Surmodics's top domains

See how Surmodics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

surmodics.com2.56

See more with Sales Intelligence

Surmodics top competitors by domain

Top similar sites in May 2026, ranked by their affinity

sawbones.comCompany NameSawbonesEmployees51 - 200HQUnited States, Washington, VashonAnnual revenue$15M - $25MTotal visits14.4KHealth > Health - Other

Top technologies used by Surmodics

These are the website technologies, by industry, used by Surmodics top domains

Conversion & Analytics (8)

Google Analytics

Email Services (3)

Sendgrid

Payment & Currencies (3)

Cart Functionality

Advertising (2)

DoubleClick

More Technologies

13

See all

News & Signals from Surmodics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSurmodics, Inc. sold assets to Endologix, Inc. on May 20th '26.Santa Rosa, Calif. - May 19, 2026 - Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the Pounce(TM) Thrombectomy System from Surmodics, Inc. The transaction closed on May 18, 2026.

NewsSurmodics, Inc. attended event 23rd Annual VIVA Conference on Nov 3rd '25.Surmodics announces PROWL Registry 160-patient data to be presented in industry-sponsored session at VIVA Conference on November 3.

NewsSurmodics, Inc. attended event 37th Annual TCT Symposium on Oct 29th '25.EDEN PRAIRIE, Minn. - (BUSINESS WIRE) - Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from a sex-specific analysis of 160 real-world acute, subacute, and chronic thrombotic limb ischemia patients from its PROWL registry study were presented by Dr. Peter Monteleone at the 37th Annual TCT Symposium in San Francisco, CA.